AN

Ananda Pharma Plc

Aquis Stock Exchange

Overview

Corporate Details

ISIN(s):
GB00BDQPXQ60
LEI:
894500DFM8VOC5FW4X47
Country:
United Kingdom
Address:
6th Floor, 60 Gracechurch Street, EC3V 0HR London
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Ananda Pharma Plc is a biopharmaceutical company focused on the development and commercialization of regulatory-approved, cannabinoid-based medicines. The company's pipeline targets complex, chronic conditions with significant unmet medical needs. Key therapeutic areas of focus include inflammatory pain conditions, such as Chemotherapy-Induced Peripheral Neuropathy (CIPN) and endometriosis, alongside drug-resistant epilepsies and Heart Failure with preserved Ejection Fraction (HFpEF). Ananda's integrated approach spans from initial research and drug candidate optimization through to conducting clinical trials and securing marketing authorizations from regulators to ensure patient access.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Ananda Pharma Plc. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-26 15:43
Post-Annual General Meeting Information
Result of Annual General Meeting
English 29.6 KB
2025-08-19 08:00
Report Publication Announcement
Webinar Presentation Release
English 21.3 KB
2025-07-30 14:49
Pre-Annual General Meeting Information
Notice of Annual General Meeting
English 21.8 KB
2025-07-30 13:44
Report Publication Announcement
Publication of Annual Report
English 44.2 KB
2025-06-23 08:00
Regulatory News Service
Key Milestone in MRX1 Path to Clinical Trials
English 23.3 KB

Automate Your Workflow. Get a real-time feed of all Ananda Pharma Plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Ananda Pharma Plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Labiana S.A. Logo
A pharmaceutical CDMO for sterile forms & manufacturer of veterinary and human medicines.
Spain LAB
Labocanna Spolka Akcyjna Logo
Cultivates and distributes hemp products, medical marijuana, and private label natural cosmetics.
Poland LCN
Labomar Logo
A CDMO developing custom supplements, medical devices & cosmetics for third-party clients.
Italy LBM
Laboratorio Farmaceutico Erfo Logo
Full-service contract manufacturer of nutraceuticals and food supplements for third-party brands.
Italy ERFO
Laboratorio Reig Jofre S.A. Logo
Global pharma firm offering R&D, manufacturing, and marketing of injectables and supplements.
Spain RJF
Laboratorios Farmaceuticos Rovi S.A. Logo
Develops & manufactures prescription drugs & provides third-party contract manufacturing.
Spain ROVI
Lavipharm S.A. Logo
Develops and distributes pharmaceuticals and consumer health products using advanced delivery systems.
Greece LAVI
Lonza Group AG Logo
A leading CDMO for pharma, biotech & nutrition, providing end-to-end development & manufacturing.
Switzerland LONN
MaaT Pharma Logo
Developing gut microbiome therapies to improve survival for cancer patients.
France MAAT
Mabion S.A. Logo
Global CDMO providing end-to-end services for developing and manufacturing complex biologic drugs.
Poland MAB